State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
NCT06679985 Phase 2
Recruiting
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Part...
Condition
Hepatocellular Carcinoma
Enrollment
72 pts
Location
United States, Australia, Canada
Sponsor
Coherus Oncology, Inc.
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT03888040 N/A
Recruiting
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strengt...
Condition
Aging
Enrollment
120 pts
Location
United States
Sponsor
Marquette University
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
540 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05897320 Phase 3
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Condition
Episodic Migraine
Enrollment
315 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06305624 N/A
Recruiting
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Al...
Condition
Alcohol Use Disorder
Enrollment
298 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06471127 N/A
Recruiting
Neuroplasticity Biomarkers in Aphasia
Condition
Aphasia
Enrollment
90 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05373017 N/A
Recruiting
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivo...
Condition
Delirium
Enrollment
528 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05993689 N/A
Recruiting
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
Condition
Pregnancy Related
Enrollment
412 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT06871774 N/A
Recruiting
Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in ...
Condition
Transcatheter Aortic Valve Replacement
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05143840 Phase 2
Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chron...
Condition
Chronic Myeloid Leukemia, Chronic Phase
Enrollment
100 pts
Location
United States
Sponsor
Augusta University
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT05929703 N/A
Recruiting
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized ...
Condition
Delirium
Enrollment
1,900 pts
Location
United States
Sponsor
University of Michigan
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI